Summary:
A multicenter randomized, double-blind, placebo-controlled, 2-arm parallel-group study to determine the efficacy and safety of clonidine hydrochloride topical gel, 0.1% in the treatment of pain associated with painful diabetic neuropathy.
Qualified Participants Must:
• Be between 18 and 85 years of age
•
Have Type 1 or Type 2 diabetes and on stable therapy for the past 3 months
•
Have chronic lower leg/feet pain for the past 3 months